Ledger.Open graph →
SEC Form D · filed October 24, 2014

Syntimmune, Inc

Offering
$26.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Richard Blumberg, M.D · NEW YORK, NYDirectorLaurence Blumberg, M.D · NEW YORK, NYExec · DirectorPaul Nardone · Atlanta, GAExec · DirectorJoel Shapiro · Atlanta, GADirectorSam Hall · New York, NYDirectorGeeta Vemuri · Deerfield, ILDirectorSeth Harrison · Cambridge, MADirectorHarvey A. Bookstein · Los ANgeles, CADirectorJeffrey R. Bruce · Concord, MAExec · DirectorSam Hall · New York, NYDirectorGeeta Vemuri · New York, NYDirectorSeth Harrison · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗